These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8010083)

  • 1. Application of NONMEM method for evaluation of relative biological availability of ofloxacin.
    Li Z; Chen G; Zhuo HT
    Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):39-42. PubMed ID: 8010083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and relative bioavailability of ofloxacin tablets in 12 healthy volunteers.
    Diao Y; Li L; Zhou GH; Cheng Y
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):110-2. PubMed ID: 1598824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ofloxacin through three administration routes.
    Zhuo HT; Lu JZ; Xia XR; Ling SS
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):411-3. PubMed ID: 7717063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: effects of age on oral drug pharmacokinetics.
    Yuen GJ; Drusano GL; Brooks J; Flor S
    Pharmacotherapy; 1992; 12(2):88-92. PubMed ID: 1570232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of population pharmacokinetics with NONMEM in clinical patients treated with amikacin by intravenous infusion].
    Chu XM; Rui JZ; Zhou YG; Dai YJ; Cai WM; Ling SS
    Yao Xue Xue Bao; 1996; 31(12):881-5. PubMed ID: 9863218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the NONMEM method to evaluation of the bioavailability of drug products.
    Kaniwa N; Aoyagi N; Ogata H; Ishii M
    J Pharm Sci; 1990 Dec; 79(12):1116-20. PubMed ID: 2079659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
    Aso R; Ohashi K; Katoh T; Ogata H
    Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of albendazole in patients with neurocysticercosis.
    Castro N; Márquez-Caraveo C; Brundage RC; González-Esquivel D; Suárez AM; Góngora F; Jara A; Urizar J; Lanao JM; Jung H
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration.
    Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):465-8. PubMed ID: 10392734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of Chinese ofloxacin].
    Hou SR
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):238-41, 255-6. PubMed ID: 8395321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotan.
    Mondick JT; Oo C; Patel D; Fujitani T; Shimizu K; Barrett JS
    Am J Ther; 2009; 16(2):106-15. PubMed ID: 19300037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and relative bioavailability of nimodipine capsules and tablets in 8 Chinese healthy men.
    Guo LQ; Tan HS; Chen G
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):295-7. PubMed ID: 8249618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.